| Thomas Carter, CRNA | |
|
150 Reynoir St, Biloxi, MS 39530-4130 | |
| (228) 436-1215 | |
| Not Available |
| Full Name | Thomas Carter |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 27 Years |
| Location | 150 Reynoir St, Biloxi, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265597561 | NPI | - | NPPES |
| 00119180 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R724157 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Merit Health Biloxi | Biloxi, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Best Anesthesia Pllc | 9436521168 | 13 |
News Archive
A lot of people were surprised when House Republicans' desire to eliminate federal funding for Planned Parenthood very nearly caused the shutdown of the federal government last week (Rovner, 4/13).
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced completion of patient enrollment in the company's two ongoing Phase III clinical trials studying eluxadoline for the treatment of diarrhea-predominant irritable bowel syndrome, or IBS-d. Both studies met their target enrollments and Furiex expects to release top line results in the first quarter of 2014.
Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer.
GVK Biosciences Private Limited , Asia's leading Contract Research Organization, today announced that it received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International for its animal facilities.
The practice of removing the white cells from blood is called leukoreduction. But despite the recommendations of two national advisory committees in 10 years that voted in favor of all patients in the United States receiving leukoreduced blood, ("universal leukoreduction"), the practice is still not wholly supported in the medical community, nor recommended by the Food and Drug Administration. Part of the reason is fear of increased cost.
› Verified 8 days ago
| Entity Name | Biloxi Anesthesiology, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942253406 PECOS PAC ID: 1658350871 Enrollment ID: O20040720000284 |
News Archive
A lot of people were surprised when House Republicans' desire to eliminate federal funding for Planned Parenthood very nearly caused the shutdown of the federal government last week (Rovner, 4/13).
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced completion of patient enrollment in the company's two ongoing Phase III clinical trials studying eluxadoline for the treatment of diarrhea-predominant irritable bowel syndrome, or IBS-d. Both studies met their target enrollments and Furiex expects to release top line results in the first quarter of 2014.
Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer.
GVK Biosciences Private Limited , Asia's leading Contract Research Organization, today announced that it received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International for its animal facilities.
The practice of removing the white cells from blood is called leukoreduction. But despite the recommendations of two national advisory committees in 10 years that voted in favor of all patients in the United States receiving leukoreduced blood, ("universal leukoreduction"), the practice is still not wholly supported in the medical community, nor recommended by the Food and Drug Administration. Part of the reason is fear of increased cost.
› Verified 8 days ago
| Entity Name | Memorial Hospital At Gulfport |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215546635 PECOS PAC ID: 2466524012 Enrollment ID: O20090515000396 |
News Archive
A lot of people were surprised when House Republicans' desire to eliminate federal funding for Planned Parenthood very nearly caused the shutdown of the federal government last week (Rovner, 4/13).
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced completion of patient enrollment in the company's two ongoing Phase III clinical trials studying eluxadoline for the treatment of diarrhea-predominant irritable bowel syndrome, or IBS-d. Both studies met their target enrollments and Furiex expects to release top line results in the first quarter of 2014.
Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer.
GVK Biosciences Private Limited , Asia's leading Contract Research Organization, today announced that it received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International for its animal facilities.
The practice of removing the white cells from blood is called leukoreduction. But despite the recommendations of two national advisory committees in 10 years that voted in favor of all patients in the United States receiving leukoreduced blood, ("universal leukoreduction"), the practice is still not wholly supported in the medical community, nor recommended by the Food and Drug Administration. Part of the reason is fear of increased cost.
› Verified 8 days ago
| Entity Name | Lifelinc Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801021464 PECOS PAC ID: 0941347447 Enrollment ID: O20130522000277 |
News Archive
A lot of people were surprised when House Republicans' desire to eliminate federal funding for Planned Parenthood very nearly caused the shutdown of the federal government last week (Rovner, 4/13).
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced completion of patient enrollment in the company's two ongoing Phase III clinical trials studying eluxadoline for the treatment of diarrhea-predominant irritable bowel syndrome, or IBS-d. Both studies met their target enrollments and Furiex expects to release top line results in the first quarter of 2014.
Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer.
GVK Biosciences Private Limited , Asia's leading Contract Research Organization, today announced that it received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International for its animal facilities.
The practice of removing the white cells from blood is called leukoreduction. But despite the recommendations of two national advisory committees in 10 years that voted in favor of all patients in the United States receiving leukoreduced blood, ("universal leukoreduction"), the practice is still not wholly supported in the medical community, nor recommended by the Food and Drug Administration. Part of the reason is fear of increased cost.
› Verified 8 days ago
| Entity Name | Best Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679286108 PECOS PAC ID: 9436521168 Enrollment ID: O20230207000883 |
News Archive
A lot of people were surprised when House Republicans' desire to eliminate federal funding for Planned Parenthood very nearly caused the shutdown of the federal government last week (Rovner, 4/13).
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced completion of patient enrollment in the company's two ongoing Phase III clinical trials studying eluxadoline for the treatment of diarrhea-predominant irritable bowel syndrome, or IBS-d. Both studies met their target enrollments and Furiex expects to release top line results in the first quarter of 2014.
Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer.
GVK Biosciences Private Limited , Asia's leading Contract Research Organization, today announced that it received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International for its animal facilities.
The practice of removing the white cells from blood is called leukoreduction. But despite the recommendations of two national advisory committees in 10 years that voted in favor of all patients in the United States receiving leukoreduced blood, ("universal leukoreduction"), the practice is still not wholly supported in the medical community, nor recommended by the Food and Drug Administration. Part of the reason is fear of increased cost.
› Verified 8 days ago
| Entity Name | Magnolia State Anesthesia Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962279711 PECOS PAC ID: 1951753888 Enrollment ID: O20240116004675 |
News Archive
A lot of people were surprised when House Republicans' desire to eliminate federal funding for Planned Parenthood very nearly caused the shutdown of the federal government last week (Rovner, 4/13).
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced completion of patient enrollment in the company's two ongoing Phase III clinical trials studying eluxadoline for the treatment of diarrhea-predominant irritable bowel syndrome, or IBS-d. Both studies met their target enrollments and Furiex expects to release top line results in the first quarter of 2014.
Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer.
GVK Biosciences Private Limited , Asia's leading Contract Research Organization, today announced that it received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International for its animal facilities.
The practice of removing the white cells from blood is called leukoreduction. But despite the recommendations of two national advisory committees in 10 years that voted in favor of all patients in the United States receiving leukoreduced blood, ("universal leukoreduction"), the practice is still not wholly supported in the medical community, nor recommended by the Food and Drug Administration. Part of the reason is fear of increased cost.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Carter, CRNA 147 Reynoir St, Suite 203, Biloxi, MS 39530-4109 Ph: () - | Thomas Carter, CRNA 150 Reynoir St, Biloxi, MS 39530-4130 Ph: (228) 436-1215 |
News Archive
A lot of people were surprised when House Republicans' desire to eliminate federal funding for Planned Parenthood very nearly caused the shutdown of the federal government last week (Rovner, 4/13).
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced completion of patient enrollment in the company's two ongoing Phase III clinical trials studying eluxadoline for the treatment of diarrhea-predominant irritable bowel syndrome, or IBS-d. Both studies met their target enrollments and Furiex expects to release top line results in the first quarter of 2014.
Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer.
GVK Biosciences Private Limited , Asia's leading Contract Research Organization, today announced that it received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International for its animal facilities.
The practice of removing the white cells from blood is called leukoreduction. But despite the recommendations of two national advisory committees in 10 years that voted in favor of all patients in the United States receiving leukoreduced blood, ("universal leukoreduction"), the practice is still not wholly supported in the medical community, nor recommended by the Food and Drug Administration. Part of the reason is fear of increased cost.
› Verified 8 days ago
Ashley Taylor Johnson, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 150 Reynoir St, Biloxi, MS 39530 Phone: 228-432-1571 | |
Ronald Allen Davis, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 180 Debuys Rd., Biloxi, MS 39531 Phone: 228-860-0157 Fax: 228-860-0157 | |
Stacy Carr, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 301 Fisher St, Biloxi, MS 39534 Phone: 228-376-6018 | |
Allan Quinn, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1720b Medical Park Dr, Biloxi, MS 39532 Phone: 678-553-8150 Fax: 678-553-8152 | |
Donna Michelle Dean, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1720 Medical Park Dr # B, Biloxi, MS 39532 Phone: 228-702-2000 | |
Scott Foster Sanders, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 301 Fisher St, Biloxi, MS 39534 Phone: 228-376-6013 | |
Roy Curtis Gavin, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2046 Beach Blvd Apt C113, Biloxi, MS 39531 Phone: 318-801-5526 |